Nu Skin Enterprises Inc Quick Ratio (NUS) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Nu Skin Enterprises Inc   (NYSE: NUS)

Nu Skin Enterprises Inc 's Quick Ratio

NUS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 0.75 below Nu Skin Enterprises Inc 's average Quick Ratio.

Within Pharmacy Services & Retail Drugstore industry only one company has achieved higher Quick Ratio in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 2227, from total ranking in the first quarter 2026 at 2560.

Explain Quick Ratio?
How much Cash & cash equivalents NUS´s has?
What are NUS´s Current Liabilities?




NUS Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change -9.71 % -1.27 % -11.08 % -25.02 % -8 %
Y / Y Cash & cash equivalent Change -27.88 % -6.16 % 21.14 % 6.38 % 13.93 %
Quick Ratio MRQ 0.75 0.78 0.91 0.99 0.93
NUS's Total Ranking # 2227 # 2560 # 2277 # 2433 # 2591
Seq. Current Liabilities Change -0.25 % -2.55 % 3.65 % -10.38 % 9.07 %
Seq. Cash & cash equivalent Change -4.5 % -16.44 % -5.2 % -4.66 % 24.27 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 2
Retail Sector # 35
Overall Market # 2233


Quick Ratio Statistics
High Average Low
1.33 0.84 0.45
(Sep 30 2011)   (Jun 30 2014)




Financial Statements
Nu Skin Enterprises Inc 's Current Liabilities $ 256 Millions Visit NUS's Balance sheet
Nu Skin Enterprises Inc 's Cash & cash equivalent $ 191 Millions Visit NUS's Balance sheet
Source of NUS's Sales Visit NUS's Sales by Geography


Cumulative Nu Skin Enterprises Inc 's Quick Ratio

NUS's Quick Ratio for the trailling 12 Months

NUS Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -12.6 % -12.1 % -15.27 % -14.87 % -14.55 %
Y / Y Cash & cash equivalent TTM Growth -3.29 % 8.65 % 9.19 % -3.11 % -5.88 %
Quick Ratio TTM 0.86 0.91 0.91 0.85 0.78
Total Ranking TTM # 1399 # 1604 # 1297 # 1400 # 1478
Seq. Current Liabilities TTM Growth -2.6 % -0.31 % -3 % -7.2 % -2.05 %
Seq. Cash & cash equivalent TTM Growth -7.72 % -1.35 % 4.5 % 1.66 % 3.68 %


On the trailing twelve months basis In spite of the year on year decrease in NUS's Current Liabilities to $256.35 millions, cumulative Quick Ratio to 0.86 above the company average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Pharmacy Services & Retail Drugstore industry 12 other companies have achieved higher Quick Ratio than Nu Skin Enterprises Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 3876.

Explain Quick Ratio?
How much Cash & cash equivalents NUS´s has?
What are NUS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Pharmacy Services & Retail Drugstore Industry # 13
Retail Sector # 173
Within the Market # 2227


trailing twelve months Quick Ratio Statistics
High Average Low
1.21 0.78 0.5
(Jun 30 2012)   (Dec 31 2014)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Pharmacy Services & Retail Drugstore Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Hwh International Inc   1.02 $ 1.662  Millions$ 1.635  Millions
Nu Skin Enterprises Inc   0.75 $ 191.386  Millions$ 256.347  Millions
Guardian Pharmacy Services Inc   0.58 $ 89.807  Millions$ 154.043  Millions
Cvs Health Corporation  0.50 $ 43,936.000  Millions$ 87,041.000  Millions
Herbalife Ltd   0.38 $ 370.500  Millions$ 973.500  Millions
Petmed Express Inc   0.32 $ 13.079  Millions$ 40.598  Millions
Zerostack Corp   0.27 $ 2.965  Millions$ 11.107  Millions

Date modified: 2026-09-12T06:18:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.